Evidence map›Paper›PMID 33746519›Full record

ReviewClinical medicine insights. Arthritis and musculoskeletal disorders2021

Therapeutic Effectiveness of AxioBionics Wearable Therapy Pain Management System in Patients with Chronic Lower Back Pain.

Philip Muccio, Josh Schueller, Miriam van Emde Boas, Norm Howe, Edward Dabrowski, David Durrant

Open access · goldAbstract readReview
In one paragraph

Review in Clinical medicine insights. Arthritis and musculoskeletal disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Philip MuccioAxiobionics, LLC, Michigan, USA.ORCID https://orcid.org/0000-0002-3058-9640
Josh SchuellerAxiobionics, LLC, Michigan, USA.
Miriam van Emde BoasUniversity of Michigan Medical School, Department of Radiology, Nuclear Medicine, Functional Neuroimaging, Cognitive and Mobility Laboratory, Michigan, USA.
Norm HoweValidation & Compliance Institute, LLC, Michigan, USA.
Edward DabrowskiOakland University Beaumont School of Medicine, Michigan, USA.
David DurrantChicago Neuroscience Institute, Illinois, USA.
Oakland University · USUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lower back pain is one of the most common medical conditions leading to a significant decrease in quality of life. This study retrospectively analyzed whether the AxioBionics Wearable Therapy Pain Management (WTPM) System, a customized and wearable electrical stimulation device, alleviated chronic lower back pain, and improved muscular function. This study assessed self-reported pain levels using the visual analog scale before and during the use of the AxioBionics WTPM System when performing normal activities such as sitting, standing, and walking (n = 69). Results showed that both at-rest and activity-related pain were significantly reduced during treatment with the AxioBionics WTPM System (% reduction in pain: 64% and 60%, respectively;

Indexed as

AxioBionics WTPM systemLower back painwearable therapy pain management system

Identifiers

PMID33746519
PMCPMC7903834
OpenAlexW3130495298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.